ORCHARD THERAPEUTICS PLC-ADR (ORTX)

US68570P2002 - ADR

16.7  +0.05 (+0.3%)

Unregistered users can only see 4 years or quarters

Examples of complete financials are available for MSFT and AAPL.

Please register or login for additional data.

TTM
(2023-9-30)
2022
(2022-12-31)
2021
(2021-12-31)
2020
(2020-12-31)
2019
(2019-12-31)
Revenue
21.84M22.66M1.68M2.60M2.51M
Cost Of Goods
6.74M6.77M230.00K860.00K810.00K
Gross Profit
15.11M15.88M1.45M1.74M1.71M
Operating Expenses
117.13M141.19M141.88M154.96M174.58M
Research and Development
72.78M92.40M86.98M88.08M117.36M
Selling, General, and Administrative Expenses
44.34M48.79M54.91M66.89M57.22M
Operating Income
-102.02M-125.31M-140.43M-153.23M-172.87M
Interest Income/Expense
25.95M-25.95M-3.29M860.00K6.12M
Other Income/Expense
N/AN/A-40.00K3.41M1.09M
Non Recurring Items
0.00-1.78MN/A-3.75MN/A
Income Before Taxes
-73.05M-153.03M-143.76M-152.71M-165.66M
Income Tax
-130.00K-2.37M830.00K-730.00K-2.24M
Net Income
-72.92M-150.66M-144.58M-151.98M-163.42M
EBITDA
-99.35M-122.57M-138.10M-151.23M-171.19M
 
Per Share Data
EPS Diluted Total Ops
-4.01-11.84-11.74-153.32-175.90
Non GAAP EPS
-4.00-11.50-3.79-1.53-1.75
 
Statistics
Gross Profit Margin
69.18%70.08%86.31%66.92%68.13%
Profit Margin
-333.88%-664.87%-8605.95%-5845.38%-6510.76%
Operating Profit Margin
-467.12%-553.00%-8358.93%-5893.46%-6887.25%

All data in USD

Charts